Sanofi-Synthélabo Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Sanofi-Synthélabo on April 15, 2004. The filing primarily announces a corporate action regarding an interim dividend and provides updates on the ongoing acquisition of Aventis. The document is incorporated by reference into the company's Registration Statement on Form F-4 regarding the proposed exchange offer.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics for the reporting period. The only specific financial figure disclosed is the interim dividend amount.
- Interim Dividend: 0.97 euro per share.
- Payment Date: May 5, 2004.
Material Changes and Corporate Actions
The Board of Directors, meeting on April 14, 2004, resolved to distribute the interim dividend mentioned above. This action follows a prior resolution adopted on February 13, 2004. The filing highlights the active status of the public offers to acquire Aventis ordinary shares in the U.S., France, and Germany, noting that these offers are being made on substantially the same terms and are subject to the same conditions.
Outlook, Risks, and Contingencies
The filing emphasizes the importance of the proposed acquisition of Aventis. It directs investors to read the Registration Statement on Form F-4 (File No. 333-112314) and the final prospectus/offer to exchange for critical information regarding the transaction. The completion of the offers is contingent upon regulatory approvals and other conditions outlined in the respective offer documents for the U.S., French, and German markets. No specific operational risks or unusual items are detailed in this specific text beyond the general contingencies of the merger.
Key Facts for Investor Verification
- Verify the dividend payment date of May 5, 2004, and the amount of 0.97 euro per share.
- Review the Form F-4 (File No. 333-112314) and the final prospectus for detailed terms of the Aventis acquisition.
- Confirm the status of the public offers in the U.S., France, and Germany, noting they are intended to expire simultaneously.
- Check the SEC website (www.sec.gov) and the AMF website (www.amf-france.org) for the full Reference Document and registration statements.